Harika Lifij SRL
Harika Lifij reported total assets of 105,370 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jun 2026).
The score of Harika Lifij shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Harika Lifij's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
Harika Lifij's financial analysis
- Solvency93.5%sector median: 52.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Harika Lifij
Harika Lifij's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1005.406.186
- VAT number
- BE1005406186
- Peppol
- Registered · 0208:1005406186 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jan 2024
- Registered office
- 1140 Evere
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Harika Lifij (SRL) has been based in Evere since 2024, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 43,243 € and equity of 98,476 €; its revenue is not published. Its solvency stands at 93.5%, above the median of its sector (52.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Harika Lifij
Companies in the same business, of comparable size and area, outside its group.
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- SpectronRx Europe Manufacture of basic pharmaceutical products Grimbergen · balance sheet 198,933 €
- Pharmacie Courouble Manufacture of basic pharmaceutical products Schaerbeek · balance sheet 129,672 €
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Evarmed Manufacture of basic pharmaceutical products Diepenbeek · balance sheet 51,346 €
- Mayaku Pharmaceutical Development Manufacture of basic pharmaceutical products Ghent · balance sheet 170,483 €
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
Frequently asked questions about Harika Lifij
What is the revenue of Harika Lifij?
Harika Lifij files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Harika Lifij?
In Belgium, the VAT number is the company number prefixed with BE: BE1005406186 for Harika Lifij, if the company is VAT-registered. Its company number (CBE) is 1005.406.186.
Where is the registered office of Harika Lifij?
According to the CBE register, the registered office of Harika Lifij is in 1140 Evere.
What is the equity of Harika Lifij?
At the close of the 2025 financial year, the equity of Harika Lifij amounts to 98,476 €, a solvency of 93.5% of total assets.
Who manages Harika Lifij?
The register lists 2 active mandates at Harika Lifij. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Harika Lifij
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →